Baxter, empresa del sector farmacéutico, suma un caso más a su lista de escándalos de corrupción. Ahora se trata de Chile, donde la Fiscalía Nacional Económica (FNE) acusa a la farmacéutica que dirige en México Jaime Alberto Upegui de coludirse con otro laboratorio para adjudicarse en forma coordinada una licitación de suero fisiológico de cloruro de sodio, uno de los insumos más utilizados en los centros de salud. Ambos laboratorios se pusieron de acuerdo para presentar propuestas de venta por arriba de los costos de mercado.
Featured News
Germany Targets Fuel Price Spikes With New Daily Cap on Increases
Mar 17, 2026 by
CPI
Visa and Mastercard Win Right to Appeal UK Ruling on Interchange Fees
Mar 17, 2026 by
CPI
Spain’s Antitrust and Energy Watchdog to Release Blackout Report Without Blame
Mar 17, 2026 by
CPI
White House, GOP Again Trying to Enact Federal Preemption of State AI Laws
Mar 17, 2026 by
CPI
Klobuchar Unveils Bill to Strengthen Court Oversight of Antitrust Settlements
Mar 17, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Behavioral Economics
Feb 22, 2026 by
CPI
Behavioral Antitrust in 2026
Feb 22, 2026 by
Maurice Stucke
Behavioral Economics in Competition Policy: Going Beyond Inertia and Framing Effects
Feb 22, 2026 by
Annemieke Tuinstra & Richard May
Agreeing to Disagree in Antitrust
Feb 22, 2026 by
Jorge Padilla
Recognizing What’s Around the Corner: Merger Control, Capabilities, and the New Nature of Potential Competition
Feb 22, 2026 by
Magdalena Kuyterink & David J. Teece